1. Home
  2. SLGL vs SGMA Comparison

SLGL vs SGMA Comparison

Compare SLGL & SGMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • SGMA
  • Stock Information
  • Founded
  • SLGL 1997
  • SGMA 1993
  • Country
  • SLGL Israel
  • SGMA United States
  • Employees
  • SLGL N/A
  • SGMA N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • SGMA Electrical Products
  • Sector
  • SLGL Health Care
  • SGMA Technology
  • Exchange
  • SLGL Nasdaq
  • SGMA Nasdaq
  • Market Cap
  • SLGL 19.3M
  • SGMA 18.4M
  • IPO Year
  • SLGL 2018
  • SGMA 1994
  • Fundamental
  • Price
  • SLGL $13.00
  • SGMA N/A
  • Analyst Decision
  • SLGL Buy
  • SGMA
  • Analyst Count
  • SLGL 1
  • SGMA 0
  • Target Price
  • SLGL $40.00
  • SGMA N/A
  • AVG Volume (30 Days)
  • SLGL 13.9K
  • SGMA 61.3K
  • Earning Date
  • SLGL 08-15-2025
  • SGMA 09-18-2025
  • Dividend Yield
  • SLGL N/A
  • SGMA N/A
  • EPS Growth
  • SLGL N/A
  • SGMA N/A
  • EPS
  • SLGL N/A
  • SGMA N/A
  • Revenue
  • SLGL $12,103,000.00
  • SGMA $311,706,094.00
  • Revenue This Year
  • SLGL N/A
  • SGMA N/A
  • Revenue Next Year
  • SLGL $31.17
  • SGMA N/A
  • P/E Ratio
  • SLGL N/A
  • SGMA N/A
  • Revenue Growth
  • SLGL 603.66
  • SGMA N/A
  • 52 Week Low
  • SLGL $3.34
  • SGMA $0.96
  • 52 Week High
  • SLGL $16.50
  • SGMA $5.12
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 87.12
  • SGMA 3.92
  • Support Level
  • SLGL $10.95
  • SGMA $2.92
  • Resistance Level
  • SLGL $12.90
  • SGMA $3.00
  • Average True Range (ATR)
  • SLGL 1.12
  • SGMA 0.01
  • MACD
  • SLGL 0.40
  • SGMA -0.37
  • Stochastic Oscillator
  • SLGL 95.73
  • SGMA 0.00

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About SGMA SigmaTron International Inc.

Sigmatron International Inc is an independent provider of electronic manufacturing services (EMS). It provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The company manufactures products like printed circuit board assemblies, electro-mechanical subassemblies, and completely assembled (box-build) electronic products which are incorporated into finished products and sold in various industries, particularly industrial electronics, consumer electronics, and life sciences. In some instances, it manufactures and assembles the completed finished product for its customers. Geographically, the company derives maximum revenue from Mexico and the rest from the United States, China, and Vietnam.

Share on Social Networks: